Weill Cornell Medicine receives DoD grant to target triple-negative breast cancer

[News]

Weill Cornell Medicine has received a $2.5 million, three-year grant from the Department of Defense (DoD) to develop therapies with fewer side effects for triple-negative breast cancer, one of the most aggressive and difficult-to-treat breast cancers.

More... (https://www.news-medical.net/news/20260716/Weill-Cornell-Medicine-receives-DoD-grant-to-target-triple-negative-breast-cancer.aspx)